Can ChatGPT provide parent education for oral immunotherapy?

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published Date:

Abstract

BACKGROUND: Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best practices of OIT. Parents of allergic children often struggle with concerns regarding OIT methodology, safety, and lack of accessible educational resources. ChatGPT is a generative artificial intelligence chatbot from OpenAI recognized for its ability to formulate human-like conversations. Although applications of artificial intelligence in medical settings continue to be explored, the effectiveness of ChatGPT as an educational resource remains unknown for OIT.

Authors

  • Jana Abi-Rafeh
    Translational Research in Respiratory Diseases Program, Meakins-Christie Laboratories, McGill University Health Centre Research Institute, Montréal, Québec, Canada; Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.
  • Diana Toscano-Rivero
    Translational Research in Respiratory Diseases Program, Meakins-Christie Laboratories, McGill University Health Centre Research Institute, Montréal, Québec, Canada; Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.
  • Bruce D Mazer
    Translational Research in Respiratory Diseases Program, Meakins-Christie Laboratories, McGill University Health Centre Research Institute, Montréal, Québec, Canada; Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada; Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada. Electronic address: bruce.mazer@mcgill.ca.